Haemostasis Flashcards
Haemostasis what
arrest of blood loss from damaged vessels. Platelets aggregate become stabilized by fibrin and arrest bleeding from severed vessels
Thrombosis what does it cause
Formation of occlusive thrombi lead to MI, ischaemic stroke
Draw flow diagram for the vascular control of platelet function
ref. notes and include mediators
Process of platelet plug formation
damage to blood vessel->exposure of platelets to collagen and vWF in extracellular matrix and exposure to thrombin->platelets adhere and activate->release of mediators->vasoconstriction+aggregation of platelets->formation of soft platelet plug
Extrinsic and intrinsic pathway cascade draw flow chart
ref. notes 7a:TF, Va:Xa, (vwf:VIII), VIIIa:IXa, Va:Xa
What does thrombin activate
FV, VIII, IX, X takes place on activated platelets. Changes shape of platelet
Initiation where
TF-expressing cells in tissues after blood, with its clotting factors leak out of the blood vessels
3 categories leading to thrombosis
Stasis, vessel wall injury, hypercoagulability
Arterial thrombosis
white clots, usually associated with atherosclerosis, form at site of vascular injury, disturbed blood flow. Large platelet component. Antiplatelet drugs. MI and strokes
Venous thrombosis
stasis/turbulent flow of blood, vascular injury, hypercoagulability of blood. Platelet component, large fibrin component and RBC. Anticoagulants.Pulmonary embolism
what do you have to make sure when treating thrombosis
balance clot formation risk and risk of haemorrhage
Antiplatelet drug what does it do and example
limits growth/decreases risk of arterial thrombosis. aspirin, P2Y12 antagonists, GPIIb-IIIa antagonists
Aspirin what does it do
irreversible inhibition of COX-1 which prevents production of TXA2 (potent platelet agonist, vasoconstrictor, mitogen) but PGI2 production not affected because COX-2 can be produced. TXA2/PGI2 PGI2 action dominates
GPIIB-IIIa antagonist
Fab fragment (Abciximab, tirofiban), small molecule inhibitor (eptifibatide), use i.v. very potent block restenosis following angioplasty, inhibits aggregation. Major thrombocytopaenia risk
Anti platelet drug use
Mostly secondary prevention, block restenosis following angioplasty. But multiple pathways to platelet activation limit effect of specific inhibition. So sometimes dual therapy e.g. aspirin+clopidogrel